Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

CStone's anti-CTLA-4 antibody CS1002 filed for clinical trial approval in Australia

prnasiaJanuary 02, 2018

Tag: CStone , inhibitors

PharmaSources Customer Service